| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.0045 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0042 | 1 |